Mid- and long-term results of surgical treatment of brachiocephalic Takayasu arteritis
10.3760/cma.j.cn112139-20230904-00090
- VernacularTitle:头臂型大动脉炎外科治疗的中长期效果分析
- Author:
Jintao SHAN
1
;
Zhaohui HUA
;
Peng XU
;
Hui CAO
;
Zhouyang JIAO
;
Likun SUN
;
Shirui LIU
;
Lei XIA
;
Wenhao XUE
;
Zhen LI
Author Information
1. 郑州大学第一附属医院腔内血管外科，郑州 450000
- Keywords:
Takayasu arteritis;
Surgical procedures, operative;
Brachiocephalic Takayasu arteritis;
Endovascular treatment;
Vascular bypass surgery
- From:
Chinese Journal of Surgery
2024;62(3):229-234
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To examine the mid - and long-term outcomes of surgical treatment of brachiocephalic Takayasu arteritis.Methods:This is a retrospective case series study. The clinical data of 39 patients,which had been diagnosed as brachiocephalic Takayasu arteritis (244 cases),who underwent surgical treatment,were analyzed between July 2012 to November 2022 at Department of Endoluminal Vascular Surgery, the First Affiliated Hospital of Zhengzhou University. There were 5 males and 34 females, aged (37.9±14.0)years (range:13 to 71 years). Despite medical treatment, the patients suffered severe ischemic symptoms continually and then underwent surgical interventions. Among them, 20 patients underwent endovascular procedures, 11 underwent open surgical procedures, and 8 underwent hybrid procedures. Patients were followed up through outpatient visits at 1, 3, 6 months after surgery and once every year later. Follow-up was conducted until November 2022. Operation status, postoperative complications and re-intervention of patients were recorded and the Kaplan-Meier survival curves were used to analyze postoperative vascular patency rates.Results:All 39 surgeries were successful, with no intraoperative death or serious complications. The follow-up period was (48.8±38.2) months(range:1 to 123 months). Thirty-three patients experienced symptom relief after surgery, and 6 patients required secondary surgical interventions. The patency rates for the endovascular treatment group at 1-, 3-, 5-, and 10-year were 95.0%, 75.2%, 60.2%, and 60.2%, respectively, while the patency rates for open surgery were all 90.9%. In the hybrid surgery group, the patency rates at 1-, 3-, 5-, and 8-year were all 87.5%.Conclusion:For patients with brachiocephalic Takayasu arteritis, choice of an appropriate blood flow revascularization intervention should be based on the patient′s condition,and the mid-and long-term outcomes are satisfactory.
